Figure 1.
Myricetin inhibits the hemolytic activity of Hla. (A) Chemical structure of myricetin. (B,C) Inhibition of Hla activity by myricetin (Myr). The hemolytic activity of purified Hla (5 μg/ml) pretreated with the indicated concentrations of myricetin was determined using a hemolysis assay. (D,E) Hemolytic activity of the supernatants from S. aureus co-cultured with myricetin. The sample treated with DMSO was regarded as a negative control, and the sample treated with Hla or the supernatants from 8325-4 strain in the presence of DMSO served as a positive control (100% hemolysis). (F) Growth curves of S. aureus in the presence of various concentrations of myricetin. (G) Western blot assay for Hla expression in the supernatants and precipitates of S. aureus cultures treated with or without myricetin. The gray value of Hla expression in the culture supernatants (H) and precipitate (I) of S. aureus cultures treated with or without myricetin using Image-Pro Plus 6.0 software. Each column shows the mean ± SD of three independent experiments and analyzed by the one-way ANOVA. *P < 0.05 and **P < 0.01 compared to the positive group.